Article
Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Mar 2010
Wang Dachun, Morales John E, Calame Daniel G, Alcorn Joseph L, Wetsel Rick A
Abstract excerpt
Respiratory diseases are a major cause of mortality and morbidity worldwide. Current treatments offer no prospect of cure or disease reversal. Transplantation of pulmonary progenitor cells derived from human embryonic stem cells (hESCs) may provide a novel approach to regenerate endogenous lung c...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
